Reappearance of inhibitor in a tolerized patient with severe haemophilia A during FVIII‐free emicizumab therapy.

MLA

Capdevila, Ladislas, et al. “Reappearance of Inhibitor in a Tolerized Patient with Severe Haemophilia A during FVIII‐free Emicizumab Therapy.” Haemophilia, vol. 27, no. 4, July 2021, pp. e581–84. EBSCOhost, https://doi.org/10.1111/hae.14334.

APA

Capdevila, L., Borgel, D., Lasne, D., Lacroix, D. S., Desvages, M., Delignat, S., Bally, C., Frenzel, L., & Harroche, A. (2021). Reappearance of inhibitor in a tolerized patient with severe haemophilia A during FVIII‐free emicizumab therapy. Haemophilia, 27(4), e581–e584. https://doi.org/10.1111/hae.14334

Chicago

Capdevila, Ladislas, Delphine Borgel, Dominique Lasne, Desmazes, Sebastien Lacroix, Maximilien Desvages, Sandrine Delignat, Cécile Bally, Laurent Frenzel, and Annie Harroche. 2021. “Reappearance of Inhibitor in a Tolerized Patient with Severe Haemophilia A during FVIII‐free Emicizumab Therapy.” Haemophilia 27 (4): e581–84. doi:10.1111/hae.14334.